Literature DB >> 19466470

Prevalence of Staphylococcus aureus strains in an Australian cohort, 1989-2003: evidence for the low prevalence of the toxic shock toxin and Panton-Valentine leukocidin genes.

S Schlebusch1, J M Schooneveldt, F Huygens, G R Nimmo.   

Abstract

The purpose of this paper is to determine the prevalence of the toxic shock toxin gene (tst) and to enumerate the circulating strains of methicillin-sensitive Staphylococcus aureus (MSSA) and methicillin-resistant S. aureus (MRSA) in Australian isolates collected over two decades. The aim was to subtype these strains using the binary genes pvl, cna, sdrE, pUB110 and pT181. Isolates were assayed using real-time polymerase chain reaction (PCR) for mecA, nuc, 16 S rRNA, eight single-nucleotide polymorphisms (SNPs) and for five binary genes. Two real-time PCR assays were developed for tst. The 90 MRSA isolates belonged to CC239 (39 in 1989, 38 in 1996 and ten in 2003), CC1 (two in 2003) and CC22 (one in 2003). The majority of the 210 MSSA isolates belonged to CC1 (26), CC5 (24) and CC78 (23). Only 18 isolates were tst-positive and only 15 were pvl-positive. Nine MSSA isolates belonged to five binary types of ST93, including two pvl-positive types. The proportion of tst-positive and pvl-positive isolates was low and no significant increase was demonstrated. Dominant MSSA clonal complexes were similar to those seen elsewhere, with the exception of CC78. CC239 MRSA (AUS-2/3) was the predominant MRSA but decreased significantly in prevalence, while CC22 (EMRSA-15) and CC1 (WA-1) emerged. Genetically diverse ST93 MSSA predated the emergence of ST93-MRSA (the Queensland clone).

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19466470     DOI: 10.1007/s10096-009-0761-1

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  33 in total

Review 1.  Superantigens: microbial agents that corrupt immunity.

Authors:  Martin Llewelyn; Jon Cohen
Journal:  Lancet Infect Dis       Date:  2002-03       Impact factor: 25.071

2.  Antimicrobial resistance in Staphylococcus aureus in Australian teaching hospitals, 1989-1999.

Authors:  Graeme R Nimmo; Jan M Bell; David Mitchell; Iain B Gosbell; John W Pearman; John D Turnidge
Journal:  Microb Drug Resist       Date:  2003       Impact factor: 3.431

3.  Rapid assay for detection of methicillin-resistant Staphylococcus aureus using multiplex PCR.

Authors:  P Barski; L Piechowicz; J Galiński; J Kur
Journal:  Mol Cell Probes       Date:  1996-12       Impact factor: 2.365

4.  Prevalence of toxic shock syndrome toxin 1-producing Staphylococcus aureus and the presence of antibodies to this superantigen in menstruating women.

Authors:  Jeffrey Parsonnet; Melanie A Hansmann; Mary L Delaney; Paul A Modern; Andrea M Dubois; Wendy Wieland-Alter; Kimberly W Wissemann; John E Wild; Michaelle B Jones; Jon L Seymour; Andrew B Onderdonk
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

5.  Toxic-shock syndrome in a male complicated by oliguric acute renal failure.

Authors:  R F Raper; L S Ibels
Journal:  Aust N Z J Med       Date:  1982-02

6.  Toxic shock syndrome associated with newly diagnosed type I diabetes.

Authors:  J J Couper; N Kallincos; A Pollard; M Honeyman; P Prager; L C Harrison; M Rischmueller
Journal:  J Paediatr Child Health       Date:  2000-06       Impact factor: 1.954

7.  Methicillin-resistant Staphylococcus aureus in the Australian community: an evolving epidemic.

Authors:  Graeme R Nimmo; Geoffrey W Coombs; Julie C Pearson; Francis G O'Brien; Keryn J Christiansen; John D Turnidge; Iain B Gosbell; Peter Collignon; Mary-Louise McLaws
Journal:  Med J Aust       Date:  2006-04-17       Impact factor: 7.738

8.  Late-onset warfarin necrosis.

Authors:  Catherine E Scarff; Chris Baker; Prue Hill; Peter Foley
Journal:  Australas J Dermatol       Date:  2002-08       Impact factor: 2.875

9.  Detection of new methicillin-resistant Staphylococcus aureus clones containing the toxic shock syndrome toxin 1 gene responsible for hospital- and community-acquired infections in France.

Authors:  Geraldine Durand; Michèle Bes; Helene Meugnier; Mark C Enright; Françoise Forey; Nadia Liassine; Aline Wenger; Ken Kikuchi; Gerard Lina; François Vandenesch; Jerome Etienne
Journal:  J Clin Microbiol       Date:  2006-03       Impact factor: 5.948

10.  Assignment of Staphylococcus aureus isolates to clonal complexes based on microarray analysis and pattern recognition.

Authors:  Stefan Monecke; Peter Slickers; Ralf Ehricht
Journal:  FEMS Immunol Med Microbiol       Date:  2008-05-27
View more
  4 in total

1.  Staphylococcal toxic shock syndrome: mechanisms and management.

Authors:  Jonathan A Silversides; Emma Lappin; Andrew J Ferguson
Journal:  Curr Infect Dis Rep       Date:  2010-09       Impact factor: 3.725

2.  Septic Pulmonary Embolism Case Report: Optimal Outcome after Insertion of an Inferior Vena Cava Filter in a Patient with Staphylococcus aureus Bacteraemia.

Authors:  Isabel Esteves; Sofia Vidal Castro; Francisco Abecasis; Cristina Camilo; Marisa Vieira; Dinis da Gama; Manuela Correia
Journal:  Int J Pediatr       Date:  2010-06-07

3.  Identification of Methicillin-Resistant Staphylococcus Aureus From Methicillin-Sensitive Staphylococcus Aureus and Molecular Characterization in Quanzhou, China.

Authors:  Zhimin Bai; Min Chen; Qiaofa Lin; Ying Ye; Hongmei Fan; Kaizhen Wen; Jianxing Zeng; Donghong Huang; Wenfei Mo; Ying Lei; Zhijun Liao
Journal:  Front Cell Dev Biol       Date:  2021-01-21

4.  Distribution of tsst-1 and mecA Genes in Staphylococcus aureus Isolated From Clinical Specimens.

Authors:  Roohollah Zarei Koosha; Hamideh Mahmoodzadeh Hosseini; Elnaz Mehdizadeh Aghdam; Shafie Ghorbani Tajandareh; Abbas Ali Imani Fooladi
Journal:  Jundishapur J Microbiol       Date:  2016-03-12       Impact factor: 0.747

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.